Similar to the results of anti-CD47 antibody treatment, inhibition of CD47 with miR-200a increased the number of NPC cells phagocytosed by macrophages (Figure 5(b)) (P < 0.01). The gene discussed is CD47; the disease is nasopharyngeal carcinoma.